Therapeutic Cannabis: CBD

CBD RESEARCH & DEVELOPMENT IN ISRAEL

Inspired by Science

THERAPEUTIC CANNABIS (CBD) INSPIRED BY SCIENCE

2 Brands, 1 Science

PROVACAN CLASSIC CBD  +  HERBALICA INFUSED CBD
SHOP NOW

WHAT WE DO

Cannabis CBD Cannabinoid Research Israel UK

SCIENTIFIC RESEARCH

CIITECH has partnered with the leading Israeli academics, institutions and organisations for innovative cannabinoid research.

 CANNABIS PRODUCTS

Designed & developed in Israel, made in the UK ensure 100% legal CBD products from our global distribution HQ in UK.

CBD PRODUCTS

Israeli developed and designed brands; PROVACAN and HERBALICA are now available from our UK online shop

PROVACAN classic CBD logo

Classic CBD Range

PROVACAN, our range of classic CBD products serving the need of customers seeking a reliable brand supported by strong company ethics and continued scientific research.

HERBALICA CANNABIS CBD BOTANICALS

CBD Infused Herbal Remedy

CIITECH has launched the HERBALICA CBD range combining traditional herbal remedies with cannabis.  Developed in Israel from years of botanical extract research.

RESEARCH & FOCUS

Our hemp derived CBD formulations are developed so consumers have full access today without the need for complex medical cannabis reform.

 Hebrew University Multidisciplinary Center Cannabis Research

Epicenter of Cannabis R&D

CIITECH selected the Hebrew University of Jerusalem as our strategic research partner.   This gold-label institution has the richest history of cannabis breakthroughs and cannabinoid therapy patents in the world.

Our initial study in partnership with Professor Raphael Mechoulam and Professor Francesca Levi-Shaffer is investigating the potential for a CBD derivative to be an effective treatment for asthma.

CIITECH CBD LIBRARY

The Science of CBD. We are continuing to research and report the latest news, knowledge and research related to Therapeutic Cannabis.

8.2 million people reported cases of anxiety in the UK

CBD suppresses the immune system and deactivates proteins that cause inflammation.

An estimated 5 million people in the UK suffer this respiratory disease

We invite you to; Connect, Follow & Engage 

facebookinstagramtwitter

CONTACT US

14 + 14 =